Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.26 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Coherus Bioscien. | 1 | 2 | 0 | 0 | €1.47 | - | - |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.63 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €5.40 | - | - |
| Arca Biopharma | 0 | 17 | 0 | 1 | €2.90 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 12 | 0 | 0 | €0.064 | - | - |
| Minerva Neurosciences Inc. | 0 | 9 | 0 | 3 | €2.92 | - | - |
| Organovo Holdings Inc. | 0 | 8 | 0 | 1 | €0.52 | - | - |
| Evoke Pharma Inc. | 0 | 25 | 0 | 2 | €0.44 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €1.31 | - | - |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €1.59 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Fibrogen Inc. | 1 | 2 | 1 | 0 | €1.15 | €4.00 | 249.040% |
| Cara Therapeutics Inc. | 11 | 4 | 0 | 2 | €0.34 | €4.62 | 1268.780% |
| Gritstone Oncology Inc | 4 | 2 | 0 | 0 | €0.64 | €5.07 | 696.619% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.82 | €5.51 | 573.333% |
| Trevena Inc. | 2 | 19 | 0 | 1 | €0.18 | €6.48 | 3541.573% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €1.11 | €6.49 | 485.334% |
| Glycomimetics Inc. | 5 | 3 | 0 | 1 | €0.20 | €7.35 | 3512.580% |
| Cellectar BioSciences Inc. | 8 | 7 | 3 | 1 | €2.18 | €10.55 | 383.752% |
| Inotiv Inc. | 3 | 1 | 0 | 0 | €1.89 | €10.66 | 464.111% |
| Cyclacel Pharmaceuticals Inc. | 2 | 10 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Elanco Animal Health Inc. | 8 | 3 | 1 | 0 | €11.81 | €15.66 | 32.640% |
| Moleculin Biotech Inc | 3 | 23 | 0 | 2 | €0.41 | €18.42 | 4393.659% |